Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c684df17c1e09127a3765f1138203f85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_633e96b87dc01751b8262dc8b333d3f9 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1271 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56938 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
filingDate |
2014-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55a6a852831d53cd1a22733a210c98d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9b2cdb71c4feacfd0e748b1bf9babce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd19d253b616d1c9a2dfd69309b23f3d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73330d2871ee33bf8208e47e3eff4b72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46397ca99bf4beed39b23473a7ba7816 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57aa6a392f02550af2167a939eb17ab7 |
publicationDate |
2018-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9944694-B2 |
titleOfInvention |
Antibodies against Staphylococcus aureus and uses therof |
abstract |
The invention relates to the field of immunology and vaccine development. In particular, it relates to antibodies and fragments thereof against Staphylococcus aureus and to therapeutic and diagnostic uses thereof. Provided is an isolated antibody or a functional fragment thereof, which binds to an epitope of the Immunodominant Staphylococcal antigen A (IsaA), wherein said antibody comprises at least four Isa A epitope-binding CDR sequences selected from the group consisting of SEQ ID NO: 1; SEQ ID NO: 2; SEQ ID NO: 3; SEQ ID NO: 4; SEQ ID NO: 5; SEQ ID NO: 6, and functional equivalents thereof having an amino acid sequence that is at least 85% identical to an amino acid sequence of SEQ ID NO: 1-6. |
priorityDate |
2013-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |